Meditherm Medical Thermal Cameras Examined
US-based Meditherm emphasized to IPVM its 20+ year development history and cameras that are designed exclusively for medical applications, including mass fever screening.
We spoke to Meditherm founder, Dr. Peter Leando, and in this report, we look at their medical thermal cameras, and how they compare to others.
*******
********* **** ****-****** (*********** ******* ****** the ***** *** *** **********), **** inner ******* *** *******/***** ***** ***********, highlighting ***** **+ ***** ** ******* detection ********** ************ ***(*) ********. **** **** ** ************ ************ for ******** ************/**** *********, ********* ***** their ******* *** *** ******, *** for * ***** *********.
*********'* **-************ ******* ***** **** $**,*** to $**,*** ****, ********* ** *** resolution, ***** ** ** *** ***** of ***-******* ******* **** *********, *****, and ******, ****** ******* ****** *** aggressive ****** ** ******** ****** ************ screening, ******* *******, ****, ***.
Company ********
********* *** ******* ** ****, *** Leandro **** *** ****** ******* **** used **** ********* ** *** **** 2010s ** *********. **** ***** ** medical ************ *** ******* ******* (*.*. cancer *********, ******** ******, **** *******, sports ********, ***), *** ********** ************.
*********'* *********** ***** ********* ****** ** the**** ***, ******** ** * *** ******* camera, **** ******** **** ******* *** a *' **** ******** *** ** multiple *********.
*** ********* *** ******** * ****** for ********** ************ ** ***** *********** WinTES3 ********.
*** ****** ** ********* *** ******* over * *** ********** **** *** laptop *** **** *** ******* ** a ******/**** ******.
********* **** *** ******* * ******* spectrum ******, ****** **** ***********, *******, while **** *** ******** ******** *********** on ****** ********, **** *** ************ scanning ** * ***** ***** *** simplify ******** ******** *** ********* *********.
Blackbody *** ******** / ********* *****
********* **** *** ******* * *********, focusing ** ** *°* **** *********** range **** ****** ** *** ****** reference ***********, ** **** ** *** camera's ************ *** ********* *********** ******** eliminate *** **** *** * *********. They **** ***** ******** ********** ******* for ******* ***** *** ******** **** to * ***** ******** ****** *********** and ******* *** ***********.
**** **** ******** **** *************** ******** in*** ***** ********* ************ *** ********* *********** ****** ** followed ** **** ** ********.
******* **** *** ***** ****** *** the *********** *** ******** ************, ********* said **** ********* ** ********* **** feature **** ********** ***** ** *** FoV **** ********* **** *** ********* adjustments (*.*. ********** *******, ******** ********). Meditherm **** **** **** *** ********* calibration ** ********** ******* *****.
Thermal **** *** *********
********* ***** *** ******** ***** ******* sensor ********, *********** **** **** *** not ******** *** ******* ************ ** the ******, *** **** **** **** challenged ** ****** ********** ******** *** to ******* ****** ******.
**** **** ******** *********** ** ***** cameras **** ** ******* *****, ***** have **** ************.
Slow ****** ***********
********* **** **** *** ********** ******* temperature ** ****-****** ****** ****** * queuing ****** *** ****** ***** *******-***** cameras (*.*.******** **) **** ** *** ******* ****** to **** **** ***** ******* *** generation *******. **** ***** **** ***** first-generation ******* ******** * ******* *** a ****** ****.
********* ********** ***** ******** ********* ** looking *** * ******** ******* ** increased *********** ****** *** ****:
**** ***** ******* ********* ** ****** the *********** ***** ** ******** ***** counts **** ** ** ****, **** the **** ** ******** ***** *********.
**** **** **** **** ***** ** temperatures **** *** *** ***, ***** could ******** ******* ******** *** ** a *****. ********* ***** **** **** could ***** ***** ****** *** ** someone **********/*******, *** **** ***** ** determined ******* ********* ********* *** ******** training.
False ******** ****
******* * *** ** *** ****** trigger****** ** ******** ********* ** *********'* report, **** **** * *** ** a *,*** ******** ** ****** * fever:
** ***** ** ***** (***) ********* in ******* ************ *** *********** ********** has **** **** *.*% (** ****** in ***** *,***) **** ******** * positive *****.
** *** *.*% *********, ********* ********* will **** **** **% ** ***** are ‘***** *********’ *** * ******* state (******** *****) *** *** ********* 18% (* ****** ** * ********) will **** * ******** *****.
**** ** *** ***** ******** ** have **** **** **** * ******** claim ** ** ****** ******** ** to ******.
Focus ** ******** ******** / *****
********* **** **** *** ** ***** concerns **** ***** ***** ******* *** non-medical *** ** * **** ** time *** ********* ** *******, *****, and ******* *********.
**** ***** **** **** **** **** minimally ******* *********** **** ** *********** thresholds ** ******* *** ************ ************, to *** ***** **** **** ***** easily **** ******* **** * *****.
Software *********** ********
********* ***** **** ******* ***** ******** and ******** ** *****, *** **** it ** ******** *** ************* ** understand *** ********* ** *** ************** and *****-**-***** ******.
********, **** *** **** ***** ******* of ********* ****** *** ******** ***** system *********** *** *** ** ** be ** ****** ** ******** *** operators.
FDA ******* ******* ******* ****
****** **** *********** *** *** ** claim ***** ********* ******* ********* ******* ***, ********* *** ***** with ** **** **** **** ******* imaging ******* **** *** ***(*) *********, not ********** ***. *** **** *********** on *** ********* ************ *** ******, see:*** ***** ******** ** '***********' ******* Fever ********* *******
*******
********* **** ***** **** ****** ***** scanning *** ** $**,*** ****, **** lower ********** ****** **** ******* $**,***.
**** ***** ******** *** ****** *** PC **** ***** ********, ** **** as ******** ******** *** *******.
**** ******* ** ********** ** **** thermal ********* *******, ***** **** *** $10,000-15,000 ***, *** ************* ***** **** Spectron **'* *******-***** ******* ($**,*** - $40,000).
************
********* ** **** ******* * ****** channel **** ** ******** ******** **** providers. **** *** ***** ****** ** coronavirus ********* ***** ********* ******** **** security *** ********* ******** *********, ***** they ***** ******** ****** **** ********* (e.g. ****, ****, *****).
*** *************, *** ************* ********* ******* *** ***** ********, *** ********* ** ************ ******* environments, ***** ********* **** **** ** not ********* *** ** ************* ********* accuracy.
Vote / ****
***** ***** ******** ****, **** ******** with *********'* ***** ****** ** ******
** ** ***** ** ***** *** their ***** ********* (****** **** ****** they ****) ***** ** *** ******. Hard ** **** ******* ****** ***** (i.e., ***** * ******** ******* ** everyone *** ** ******* ** *** thermal ******).
**** **** **** *** *** ********* to ********. * *** ******* ** it **** **** *** ***** **: detect * ***** (******* ** *** majority ** *****) -> ******* * response (** **** ****). **** ********* will ** ****** *** *** *********?
****** **** ** ******** ***** *********/***** positives ****. **** **** ** *********** where *** ****** ** *** **** is ********** ***** *** ***** ** so **** ** *******.
*********** **** *** **** *********'* **** comes **** ******* ** ***** *** - - *** ***** ***** ****** market, ** *** ****** ********* ********* from ****** * ******** ***********, ***** is * **** **** ********** *********** than ** ********* ** ******* *** mass ******** ********* ********.
** *** **** * ******* ** actually ***** ******* ** * ****** professional ** * ******** ***********, ****'** usually **** **** ** * ********** waiting ***** *** **-** ******* ** more.
** **** ******** ** **** *********** and **'* ******** ******* ************.
****'* ***** * **** ********* ******* in ******** ** **** *******. **** appreciated!
**** * **** **** *********** ** the ******** ***** ********* ***** **** widescale *********** ** ************* ******* *** well *********. * ***** ******* **** in ***** ** *** ******* ******** of *** ******** ** *** ******* being ********, ***** ***** ******** ****, when ******** **** *********'* ***** ****** be ******.